{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T21:35:12Z","timestamp":1772487312542,"version":"3.50.1"},"reference-count":24,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,14]]},"abstract":"<jats:p>Visco and colleagues report excellent response to eltrombopag in immune thrombocytopenia in the setting of chronic lymphoproliferative disease.<\/jats:p>","DOI":"10.1182\/blood.2019001617","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T20:15:25Z","timestamp":1569874525000},"page":"1708-1711","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-0883","authenticated-orcid":false,"given":"Carlo","family":"Visco","sequence":"first","affiliation":[{"name":"Division of Hematology, San Bortolo Hospital, Vicenza, Italy;"},{"name":"Department of Medicine, Section of Haematology, University of Verona, Verona, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Rodeghiero","sequence":"additional","affiliation":[{"name":"Division of Hematology, San Bortolo Hospital, Vicenza, Italy;"},{"name":"Hematology Project Foundation, Vicenza, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[{"name":"Hematology, University Hospital, Catania, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Valeri","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, Citt\u00e0 della Salute e della Scienza, Torino, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-5927","authenticated-orcid":false,"given":"Michele","family":"Merli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Insubria, Varese, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Quaresimini","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Volpetti","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit, University Hospital, Udine, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-2749","authenticated-orcid":false,"given":"Roberto M.","family":"Santi","sequence":"additional","affiliation":[{"name":"Hematology, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Carli","sequence":"additional","affiliation":[{"name":"Division of Hematology, San Bortolo Hospital, Vicenza, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Lucchini","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit, University Hospital, Udine, Italy;"},{"name":"Department of Haematology, University Hospital, Trieste, Italy; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Insubria, Varese, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Motta","sequence":"additional","affiliation":[{"name":"Hematology, University Hospital, Catania, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Borchiellini","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, Citt\u00e0 della Salute e della Scienza, Torino, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele S. G.","family":"d\u2019Amore","sequence":"additional","affiliation":[{"name":"Institute of Pathology, San Bortolo Hospital, Vicenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ruggeri","sequence":"additional","affiliation":[{"name":"Division of Hematology, San Bortolo Hospital, Vicenza, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"issue":"21","key":"2019111521133168700_B1","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2019111521133168700_B2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminhematol.2014.10.006","article-title":"Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists","volume":"52","author":"Rodeghiero","year":"2015","journal-title":"Semin Hematol"},{"issue":"22","key":"2019111521133168700_B3","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111521133168700_B4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.hoc.2009.08.006","article-title":"Immune thrombocytopenia in lymphoproliferative disorders","volume":"23","author":"Visco","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"26","key":"2019111521133168700_B5","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111521133168700_B6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood-2007-09-111492","article-title":"Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia","volume":"111","author":"Visco","year":"2008","journal-title":"Blood"},{"issue":"23","key":"2019111521133168700_B7","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2010-05-286500","article-title":"Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance","volume":"116","author":"Moreno","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111521133168700_B8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med"},{"issue":"27","key":"2019111521133168700_B9","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Caligaris-Cappio","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019111521133168700_B10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23785","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia","volume":"89","author":"Visco","year":"2014","journal-title":"Am J Hematol"},{"issue":"2","key":"2019111521133168700_B11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.seminoncol.2006.01.011","article-title":"Autoimmune complications of chronic lymphocytic leukemia","volume":"33","author":"Hamblin","year":"2006","journal-title":"Semin Oncol"},{"key":"2019111521133168700_B12","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"1","key":"2019111521133168700_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"issue":"5","key":"2019111521133168700_B14","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/leu.2010.45","article-title":"Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP","volume":"24","author":"Koehrer","year":"2010","journal-title":"Leukemia"},{"key":"2019111521133168700_B15","unstructured":"European Medicines Agency\n          . Revolade (eltrombopag). Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/revolade#product-information-section. Accessed 2 May 2019."},{"issue":"3","key":"2019111521133168700_B16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bjh.15581","article-title":"A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia","volume":"185","author":"Paul","year":"2019","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111521133168700_B17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/10428194.2010.542598","article-title":"Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia","volume":"52","author":"D\u2019Arena","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111521133168700_B18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/09537104.2011.634931","article-title":"Thrombopoietin-receptor agonists in haematological disorders: the Danish experience","volume":"23","author":"Gudbrandsdottir","year":"2012","journal-title":"Platelets"},{"issue":"4","key":"2019111521133168700_B19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/10428194.2010.551794","article-title":"Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia","volume":"52","author":"Sinisalo","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2019111521133168700_B20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/10428194.2010.547643","article-title":"Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?","volume":"52","author":"Tadmor","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2019111521133168700_B21","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00277-017-2953-6","article-title":"Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists","volume":"96","author":"Rodeghiero","year":"2017","journal-title":"Ann Hematol"},{"issue":"3","key":"2019111521133168700_B22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bjh.14881","article-title":"Transformed Waldenstr\u00f6m macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)","volume":"179","author":"Durot","year":"2017","journal-title":"Br J Haematol"},{"issue":"11","key":"2019111521133168700_B23","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111521133168700_B24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.24234","article-title":"Is ITP a thrombophilic disorder?","volume":"91","author":"Rodeghiero","year":"2016","journal-title":"Am J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/20\/1708\/1506044\/bloodbld2019001617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/20\/1708\/1506044\/bloodbld2019001617.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T23:45:48Z","timestamp":1573861548000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/20\/1708\/375012\/Eltrombopag-for-immune-thrombocytopenia-secondary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":24,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2019,9,30]]},"published-print":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019001617","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]}}}